Blue Trust Inc’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $389K | Buy |
2,562
+155
| +6% | +$23.5K | ﹤0.01% | 539 |
|
|
2025
Q1 | $362K | Buy |
2,407
+904
| +60% | +$136K | ﹤0.01% | 505 |
|
|
2024
Q4 | $277K | Sell |
1,503
-374
| -20% | -$69K | ﹤0.01% | 549 |
|
|
2024
Q3 | $388K | Buy |
1,877
+418
| +29% | +$86.4K | 0.01% | 560 |
|
|
2024
Q2 | $395K | Buy |
1,459
+234
| +19% | +$63.4K | 0.01% | 467 |
|
|
2024
Q1 | $332K | Buy |
1,225
+240
| +24% | +$65K | ﹤0.01% | 368 |
|
|
2023
Q4 | $193K | Buy |
985
+177
| +22% | +$34.7K | ﹤0.01% | 456 |
|
|
2023
Q3 | $170K | Buy |
808
+682
| +541% | +$143K | ﹤0.01% | 476 |
|
|
2023
Q2 | $26K | Sell |
126
-1,140
| -90% | -$235K | ﹤0.01% | 944 |
|
|
2023
Q1 | $276K | Buy |
1,266
+364
| +40% | +$79.4K | ﹤0.01% | 434 |
|
|
2022
Q4 | $178K | Buy |
902
+899
| +29,967% | +$177K | ﹤0.01% | 494 |
|
|
2022
Q3 | $1K | Sell |
3
-85
| -97% | -$28.3K | ﹤0.01% | 1900 |
|
|
2022
Q2 | $25K | Buy |
+88
| New | +$25K | ﹤0.01% | 896 |
|